TARGETSCAPE
LIVE

Serial Number

79271806

Owner

immunoscape Pte Ltd

Filing Date

Aug 14, 2019

Add to watchlist:

No watchlists yet
View on USPTO

TARGETSCAPE Trademark

Serial Number: 79271806 • Registration: 6010552

TARGETSCAPE is a trademark filed by immunoscape Pte Ltd on August 14, 2019. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

immunoscape Pte Ltd (5 trademarks)

1 Scotts Road
Singapore 228208 , SG

Entity Type: 99

Trademark Details

Filing Date

August 14, 2019

Registration Date

March 17, 2020

Published for Opposition

December 31, 2019

Goods & Services

Laboratory reagents for scientific use; laboratory reagents for scientific use; reagents for laboratory purposes, other than for medical or veterinary purposes; reagents and reagents in kit form for scientific research use; diagnostic biochemical, chemical and biological reagents for laboratory or scientific purposes, other than for medical or veterinary use; reagents for use in biological analysis; reagents and reagents in kit form for immune profiling

Laboratory research services in the field of biotechnology; laboratory research services in the field of immune profiling; laboratory research services in the field of vaccines; laboratory research services in the field of immunotherapy; laboratory research services in the field of immunotherapy products; laboratory research services relating to vaccines for use in the field of immunotherapy; laboratory research services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; laboratory research services, namely, probing for multiple t cell specificities for identification of tumor antigen-specific T cells for the treatment of cancer; laboratory research services, namely, probing for multiple T cell specificities for identification of viral antigen-specific T cells in the field of infectious diseases; laboratory research services, namely, phenotypic and functional t cell and/or other immune cells profiling for use in the field of immunotherapy; laboratory research services, namely, analysis by time-of-flight mass cytometry; laboratory research services, namely, analysis by flow cytometry; laboratory research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; laboratory research services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system

Filing History

NOTIFICATION PROCESSED BY IB
May 15, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Apr 28, 2020 FICS
FINAL DISPOSITION PROCESSED
Apr 28, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Apr 16, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Mar 17, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Jan 4, 2020 GPNX
PUBLISHED FOR OPPOSITION
Dec 31, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTICE OF PUBLICATION
Dec 11, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 25, 2019 CNSA
APPLICATION FILING RECEIPT MAILED
Nov 22, 2019 MAFR
ASSIGNED TO EXAMINER
Nov 18, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 14, 2019 REPR